Effect of a Multidomain Lifestyle Intervention on Estimated Dementia Risk
Alina Solomon1,2, Ron Handels3,4,5, Anders Wimo5
1Institute of Clinical Medicine/Neurology, University of Eastern Finland, Kuopio, Finland.
Journal of Alzheimer'S Disease : JAD
|June 21, 2021
Summary
A multidomain lifestyle intervention significantly reduced dementia risk in older adults by 6.5% over two years. This finding highlights the potential of lifestyle changes for cognitive health prevention.
Area of Science:
- Gerontology
- Neurology
- Preventive Medicine
Background:
- The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) evaluated a multidomain lifestyle intervention.
- This post-hoc analysis focused on the intervention's effect on dementia risk using the CAIDE risk score.
Discussion:
- The intervention group showed a statistically significant reduction in the CAIDE dementia risk score compared to the control group.
- The observed risk reduction suggests a tangible benefit of the intervention in mitigating dementia risk.
Key Insights:
- A 2-year multidomain lifestyle intervention led to a mean difference of -0.16 in the CAIDE risk score (p=0.013).
- This translates to a relative dementia risk reduction of approximately 6.04-6.50%.
Outlook:
- The FINGER intervention demonstrates significant potential for dementia risk reduction in at-risk older populations.
- Further research can explore long-term effects and broader implementation strategies for lifestyle-based cognitive prevention.
Related Concept Videos
Dementia
267
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
267
Lifestyle Factors and Health
250
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
250
Alzheimer's Disease: Overview
934
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
934
Alzheimer's Disease: Treatment
448
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
448
Hypertension IV: Drug Therapy and Lifestyle Modifications
206
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
206
Atherosclerosis III: Management
87
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87


